Topic Hub
18 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 18 of 18 clinical reviews.
A physician-reviewed breakdown of the pharmacodynamic and pharmacokinetic relationship between CJC-1295 (modified GRF) and 5-HTP, covering serotonin syndrome risk, dose-separation windows, monitoring, and when to stop.
Read clinical reviewAlpha-lipoic acid and CJC-1295 (modified GRF 1-29) share overlapping effects on blood glucose and thyroid hormone metabolism. Learn the pharmacodynamic interaction, dose-separation strategy, and monitoring plan.
Read clinical reviewA clinician-reviewed guide to combining berberine with CJC-1295 modified GRF: pharmacokinetic interactions, pharmacodynamic overlap, glucose monitoring, dosing strategy, and when to hold one agent.
Read clinical reviewA clinician-reviewed breakdown of the caffeine and CJC-1295 interaction: pharmacokinetics, pharmacodynamics, glucose effects, blood pressure, timing windows, and monitoring guidance.
Read clinical reviewEvidence-based guide on combining calcium supplements with CJC-1295 (modified GRF 1-29). Covers pharmacokinetic and pharmacodynamic considerations, dose-separation windows, and monitoring recommendations.
Read clinical reviewEvidence-based guide on combining creatine supplementation with CJC-1295 (modified GRF 1-29). Covers the creatinine elevation concern, renal monitoring protocols, dose-separation windows, and clinical safety data.
Read clinical reviewA clinician-reviewed guide to combining glycine with CJC-1295 modified GRF: mechanism, pharmacodynamic interactions, dosing windows, glycemic monitoring, and safety evidence.
Read clinical reviewEvidence-based guide on combining green tea extract (EGCG) with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interactions, hepatotoxicity risk, dose-separation strategies, and monitoring recommendations.
Read clinical reviewA physician-reviewed guide to combining L-theanine with CJC-1295 (modified GRF). Covers mechanisms, any pharmacokinetic or pharmacodynamic interactions, dosing windows, and clinical monitoring.
Read clinical reviewA clinician-reviewed guide to combining lion's mane mushroom with CJC-1295 modified GRF: mechanism, interaction type, safety data, monitoring, and dosing guidance.
Read clinical reviewEvidence-based guide to combining melatonin with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction mechanisms, dose-separation windows, glucose monitoring, and clinical recommendations.
Read clinical reviewEvidence-based guide on combining NAC with CJC-1295 modified GRF. Covers interaction mechanisms, dose-separation windows, monitoring, and safety considerations.
Read clinical reviewEvidence-based guide to taking quercetin with CJC-1295 modified GRF. Covers CYP3A4 inhibition, pharmacokinetic overlap, dose-separation strategy, and clinical monitoring.
Read clinical reviewA physician-reviewed guide to the CJC-1295 and reishi mushroom interaction: mechanisms, safety evidence, monitoring parameters, and clinical recommendations.
Read clinical reviewSt. John's Wort is a potent CYP3A4 inducer that may alter CJC-1295 metabolism. Learn the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to do if you already take both.
Read clinical reviewEvidence-based guide on combining vitamin B12 supplementation with CJC-1295 modified GRF, covering interaction risk, dose timing, monitoring, and clinical considerations.
Read clinical reviewEvidence-based guide on combining vitamin D supplementation with CJC-1295 modified GRF. Covers interaction mechanisms, dosing windows, monitoring labs, and safety considerations.
Read clinical reviewEvidence-based guide on combining zinc supplements with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, copper balance, and clinical monitoring.
Read clinical review